申请人:Zeneca Limited
公开号:US05589489A1
公开(公告)日:1996-12-31
Compounds of formula I ##STR1## wherein Q.sup.1, Q.sup.2, Q.sup.3, and Q.sup.4 have any of the meanings given in the specification, their N-oxides, and their pharmaceutically acceptable salts are nonpeptide antagonists of neurokinin A and useful for the treatment of asthma, etc. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula I and intermediates.
式I的化合物##STR1##其中Q.sup.1、Q.sup.2、Q.sup.3和Q.sup.4具有规范中给定的任意含义,它们的N-氧化物以及它们的药用盐是神经激肽A的非肽拮抗剂,可用于治疗哮喘等。还公开了制药组合物、制备式I化合物和中间体的方法。